Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
looking for a full-time (100%) doctoral scholarship holder in the field of Vaccinology, within the pneumococcal carriage study. Position You will work actively on the preparation and defence of a PhD thesis
-
will contribute to attracting national and international research funding. You will assist in the supervision of PhD students and other team members. If necessary, you will fulfill a limited number of
-
back boundaries and set a course for the future – a future that you can help to shape. A-PECS at the Department of Bioscience Engineering in the Faculty of Science is looking for a full-time (100%) PhD
-
%) doctoral scholarship holder in the field of CRISPR/Cas-mediated photoelectrochemical biosensors. The overall goal of this PhD is the development of photoelectrochemical biosensors integrating CRISPR/Cas
-
of economics and development. Position You will work actively on the preparation and defence of a PhD thesis in the field of economics and development. The PhD project will use theory and survey experiments
-
a PhD thesis in the field of immuno-oncology, with a focus on Dendritic Cell (DC)-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC). The objective of this project is to decipher PDAC
-
the (Social) Science Citation Index. You will assist in the coordination of ongoing research projects and the activities of the research group. You will support PhD students in the preparation of their PhD
-
host institution. Profile You hold a PhD in Heritage Studies, Urban Studies, Sociology, History or any other relevant field (or you will have obtained it by the time you start work). Your research
-
”. Position You will work actively on the preparation of a PhD thesis in the field of functional genomics of neurovascular diseases. You will publish high-quality scientific articles related to the research
-
the preparation and defence of a PhD thesis in the field of Medical Sciences. More specific, you will work on the validation of predictive peptide biomarkers to classify non-small cell lung cancer (NSCLC) patients